News
MeDeMSA research group annual meeting on May 3rd 2024 in Innsbruck
A team of scientists dedicated to improving MSA diagnosis and care. A very important person was missed this year, Prof. Wenning's teaching was still with us though: to focus on what counts for a person who lives with MSA.
A 6-item score for early MSA-P
Despite technological progress, MSA is often diagnosed four to five years into the disease course. This is a major hurdle for a timely engagement in clinical trials with disease-modifying candidate drugs. In this cooperation with the amazing Tel Aviv and Belgrade teams, we developed a bedside 6-items score to early identify people at high risk of suffering from the parkinsonian variant of MSA.
Read more under: https://doi.org/10.1002/mdc3.14048
Do men and women differ? Of course they do.
Does this impact on the clinical presentation of MSA? In fact it does Read more in this paper by Dr Fabian Leys and the Innsbruck team: https://rdcu.be/dFrPj
Isolated Temporal Muscle Thickness measurement on MRI has no prognostic relevance on survival in patients with Multiple System Atrophy
Geführte Poster-Präsentation von Dr. F. Jagusch (PhD-Student im Rahmen der MeDeMSA Forschungsgruppe) zum Thema "Isolated Temporal Muscle Thickness measurement on MRI has no prognostic relevance on survival in patients with Multiple System Atrophy“ im Rahmen der Jahrestagung der österreichischen Gesellschaft für Neurologie (Wien, März 2024)
Autonomy and Neurodegenerative Diseases Conference in Zürich on September, 2nd and 3rd 2024
SAVE THE DATE!
Autonomy and Neurodegenerative Diseases Conference in Zürich September, 2nd and 3rd 2024
Organizers:
Daniel Lucas (Zürich), Mario Kropf (Graz), Martina Schmidhuber (Graz)
Speaker:
Among many others: Stefan Lorenzl, Caroline Breitegger, Martina Schmidhuber
MeDeMSA Expertenworkshop on October 9th 2023
Expert workshop MeDeMSA working group
On October 9, 2023, the expert workshop of the MeDeMSA (Medical Decision Making in MSA) working group focused on the theme of 'MeDeMSA: HTA-supported medical decision making in MSA.' The event was hosted at Innsbruck University Hospital and led by Assoc.-Prof. Beate Jahn (UMIT TIROL), with the participation of national and international experts. In the project, a decision analysis will assess MSA diagnostics and treatment for both standard care and personalized best medical care, including telemedicine. The established interdisciplinary Standing-Expert Panel, comprising experts from the Universities of Innsbruck, Graz, London, UMIT TIROL, as well as Tirol Kliniken and i-HTS - International HealthTechScan, provided insights for decision analysis and the Health Technology Assessment Framework.
A follow-up workshop is planned for 2024.
Congress of the European Federation of Autonomic Societies, Oktober 6th 2023
The Innsbruck Dysautonomia Team at the 2023 congress of the European Federation of Autonomic Societies in Dubrovnik, Croatia on October 6th. Team members talked about the latest research on the prodromal stages and treatment strategies for MSA.
From left to right: Dr.in Bianca Caliò, MD; Heidi Halbedl, MA; Jean-Pierre Ndayisaba, DI (FH) DI PhD; Bettina Unterwurzacher; Dr.in Nicole Campese, MD; Karoline Radl, DMTF; Assist. Prof.in Dr.in Alessandra Fanciulli, MD, PhD; Prof. Gregor K. Wenning, MD, PhD, MSc; Assist. Prof.in Dr.in Roberta Granata
Bladder scan training on September 25th 2023
at the Innsbruck Dysautonomia Center for the MeDeMSA Care research program. Multidimensional assessments are key for an individualized MSA treatment - powered by the #FWF Austrian Science Fund
MeDeMSA Kick-Off Meeting on April 14th 2023 in Innsbruck
